Helping you conduct post-approval studies on a global scale

Phase IV Studies

Phase IV is a generic term to qualify studies occurring after FDA or CHMP approval of a health product for marketing (in contrast to Phases I to III studies that occur during pre-approval period). Phase IV studies include several study designs depending of the scientific objective. From a randomized clinical trial (usually based on large number of patients with minimum data collection and monitoring “large simple trials”), to non-interventional/observational studies using epidemiological methods.

Request a consultation with an RWE expert

First Name* Last Name*
Job Title Company Country* Your Email*
Phone number* Mobile number
What would you like to enquire about? Subscribe to receive ICON updates?

Please read Mapi Privacy Policy, any personal data you submit to us as part of your enquiry will be processed by Mapi in accordance with the Mapi privacy policy.